Results 211 to 220 of about 4,318,091 (252)

Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis. [PDF]

JCI Insight
Wang Y, Adeleke D, Xie X, Yang ZF, Wang X, Loi G, Yang Vom Hofe A, Singh M, Malik A, Kudira R, Castro-Rojas C, Pfuhler L, Alquraish M, Sylvestre P, Dillman JR, Trout AT, Miraldi ER, Miethke AG.   +17 more
europepmc   +1 more source

Radiomics-Based Prognostication in Primary Sclerosing Cholangitis: A Proof-of-Concept Study. [PDF]

Liver Int
Cristoferi L, Maino C, Bernasconi DP, Ripamonti I, Scaravaglio M, Savino A, Pesatori E, Gerussi A, Nofit E, Falco O, D'Amato D, Gallivanone F, Alberzoni C, Viganò R, Mazzarelli C, Belli LS, Dinelli ME, Mutignani M, Valsecchi MG, Corso R, Invernizzi P, Carbone M, Ippolito D, Bernardi E.   +23 more
europepmc   +1 more source

Primary sclerosing cholangitis displays distinct colonic mucosa topography yet a shared mast cell state with ulcerative colitis. [PDF]

Nat Commun
Tearle JL, Sviriaeva E, Zhang F, Jackson KJ, Kaye J, Tavakoli P, Koentgen S, Warren J, Liang RR, Malhotra P, Williams C, Haque A, Arzivian A, Sudhakar KK, Neavin D, Tedla N, Kim A, Haifer C, King HW, Hold GL, Ghaly S, James KR.   +21 more
europepmc   +1 more source

Serum Anti-<italic>Saccharomyces cerevisiae</italic> Antibody Is Associated with Disease Severity in Patients with Primary Sclerosing Cholangitis.

Dig Dis
Zmora N, Bannon L, Tzadok R, Nachmias N, Leibovitzh H, Zigmond E.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Primary sclerosing cholangitis

The American Journal of Surgery, 1971
Abstract Primary sclerosing cholangitis is an uncommon condition of unknown etiology, presenting extrahepatic biliary obstruction due to a chronic inflammatory obliterative process. Criteria for diagnosis include progressive biliary obstruction due to a chronic inflammatory fibrous process, absence of biliary stones, absence of biliary surgery prior ...
A W, Perry, E, Djang, G, Kafrouni, L G, Ludington   +3 more
openaire   +2 more sources

Primary sclerosing cholangitis

Current Problems in Surgery, 1992
Primary sclerosing cholangitis is a condition of unknown cause. It is recognized by liver dysfunction and its characteristic radiologic appearance, which is related to portal tract inflammation, bile duct proliferation, and periductal fibroses involving small intrahepatic and large extrahepatic ducts.
F M, Martin, J W, Braasch
openaire   +2 more sources

Primary Sclerosing Cholangitis

Archives of Internal Medicine, 1965
Mr. A is 32 years old. He was diagnosed with ulcerative colitis at the age 19 and is managed with five ASAs. He sees his IBD specialist on a yearly basis. His last colonoscopy was 3 years ago. At his last appointment, he was found to have abnormal liver biochemistry (bilirubin 23, alkaline phosphatase (ALP) 243, ALT 65, AST 72, gamma glutamyl ...
J G, MANESIS, J F, SULLIVAN
openaire   +2 more sources

Primary sclerosing cholangitis

Clinics in Liver Disease, 2004
Primary sclerosing cholangitis is a cholestatic liver disease strongly associated with IBD. Considerable advances in the understanding of its pathogenesis have been made. The idea of autoimmunity affecting genetically susceptible individuals is largely accepted; however, much remains to be explained about the origin of this disease.
Flavia D, Mendes, Keith D, Lindor
openaire   +2 more sources

Primary sclerosing cholangitis

Current Treatment Options in Gastroenterology, 2001
There is no proven medical therapy for primary sclerosing cholangitis. The goal of management should be treatment of symptoms and complications of cholestasis, as well as attempts at treating the underlying disease process. In addition, efforts should be made to recognize and treat or prevent the known complications of primary sclerosing cholangitis ...
Young-Mee, Lee, David J., Kim
openaire   +2 more sources